Modern Slavery Statement

 

  1. Introduction

 

This statement is made pursuant to section 54 of the Modern Slavery Act 2015.

 

Genmed Enterprises International Ltd (Genmed) is committed to preventing modern slavery and human trafficking in all aspects of our business and supply chain. We recognize our responsibility to uphold human rights and ensure ethical practices across our operations. Among Genmed’s wholly owned subsidiaries, this statement pertains to the activities of Genmed, which is responsible for procuring goods and services on its behalf.

 

  1. Our Business and Supply Chain

 

Genmed operates in the Medical Technology (MedTech) industry and engages with suppliers, contractors, and partners globally. Our staff are directly employed and are not in any category which is generally seen to be vulnerable to modern slavery in this country, so our focus is to ensure there are policies and procedures in place for our contractors and suppliers. Genmed is committed to continuously improving its practices to identify and eliminate any slavery and human trafficking in its business and supply chains, and to acting ethically and with integrity in all its business relationships.

 

  1. Policies and Commitments

 

We have implemented policies to reinforce our stance against modern slavery, including:

  • Supplier Code of Conduct which sets out internal requirements for buying goods and services.
  • Human Rights and Ethical Business Policy covering issues of human rights, child and forced labour and modern slavery, which Genmed suppliers are required to comply with; and
  • Whistleblowing Policy which encourages staff to report concerns including any related to modern slavery/trafficking and child or forced labour.

 

  1. Risk Assessment and Due Diligence

 

We regularly assess risks related to modern slavery within our business and supply chain. After thorough assessments, we haven’t identified any high risks within our supply chain. However, any suppliers which we class as high risk must:

 

  • Complete our Modern Slavery Act Due Diligence Questionnaire which covers their governance, policies, training, and supply chain management processes; and
  • On an annual basis and prior to sourcing, provide full detail of the supply chains they are proposing to commission goods from on behalf of Genmed
  • Abide by the Service Level Agreement set out in the contract.

 

Our team is responsible for assessing the information submitted by suppliers.

 

Should a supplier fail to provide the information requested or to meet Genmed expectations, Genmed will take appropriate action, which may include not entering a relationship or terminating the relationship with the supplier concerned.

 

  1. Training and Awareness

 

We provide training to those teams who have direct responsibility for relevant supply chains and our Procurement team has participated in further modern slavery training to raise awareness about modern slavery risks and reinforce our commitment to ethical business practices. We also maintain a Modern Slavery Act Guidance document which is available to all staff through Genmed’s intranet.

 

  1. Monitoring and Performance Indicators (KPI’s)

 

We measure our effectiveness in combating modern slavery through our policies, training, and due diligence.

 

6.1. Policies

  • Modern Slavery Policy
  • Human Rights and Ethical Business Practices Policy.

 

6.2. Training

Third party training required for all new employees and selected suppliers, to:

  • Understand indicators of modern slavery
  • Understand how to report suspicions of modern slavery
  • Understand the Modern Slavery Statement requirements
  • Understand how to understand modern slavery risks in procurement.

 

6.3. Due Diligence

  • Suppliers must sign the Supplier Code of Conduct
  • Supplier compliance assessments
  • Continuous improvement initiatives and risk assessments to enhance our anti-slavery efforts
  • Training for employees to become better equipped to undertake modern slavery due diligence on behalf of Genmed.

 

 

 

 

  1. Looking Ahead

 

Over the course of the next financial year we will continue to enhance our procedures to help us identify, prevent and mitigate any risks of modern slavery or human trafficking in relation to new and existing suppliers.

 

  1. Approval and Review

 

This statement is made pursuant to Section 54 of the UK Modern Slavery Act 2015 and reflects our commitment for the financial year 2024. This statement has been formally approved by Genmed Enterprises Ltd and the Directors of Genmed Enterprises Ltd.

 

 

Name:            Meirion Thomas
Position:        Director
Date:              03/09/2024